Updated: Feb 24
Based on endoscopy technology, Auris Health has announced that its Monarch robotic system designed for diagnosing and treating lung cancer tumours has gained FDA approval. The competitive advantage of the Monarch system is computer-aided navigation, which should result in better clinical diagnosis as well as greater capacity to treat small and hard-to-reach lung nodules. Although lung cancer is the primary target, co-founder and CEO Frederic Moll (formerly of Intuitive Surgical) said in a prepared statement that the company would like to apply their technology to other endoscopic procedures in the future. The objective for robotic surgery is to offer more natural controls for surgeons whilst adopting less invasive procedures for patients to prevent trauma – Auris Health joins the line of other peers such as Titan Medical, Mazor Robotics and TransEnterix all with FDA clearance for their robots.